Tuesday's Highlights at Noon: Cormedix Inc (CRMD), Anthera Pharmaceuticals (ANTH), Twitter (TWTR), American … – Analyst Ratings

So far Tuesday, March 20, NASDAQ is down -0.52% and the S&P is down -0.36%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Cormedix Inc (NYSE MKT:CRMD), Anthera Pharmaceuticals (NASDAQ:ANTH), Twitter (NYSE:TWTR), American Green Inc (Other OTC:ERBB) and Growlife Inc (Other OTC:PHOT).

Cormedix Inc is down -20.55% in midday trading to $0.25. Shares opened today at $0.31. The company has a 52-week low of $0.23 and a 52-week high of $1.77.

Anthera Pharmaceuticals is down -11.55% in midday trading to $0.32. Shares opened today at $0.36. The company has a 52-week low of $0.31 and a 52-week high of $3.84. On the Street’s front, the average 12-month analyst price target for the stock is $3.40, marking a 834.84% potential upside from current levels. In a report issued on March 12, Jefferies Co. analyst Matthew Andrews reiterated a Hold rating on ANTH, with a price target of $0.50, which implies an upside of 37% from current levels. Separately, on the same day, Piper Jaffray’s Edward Tenthoff downgraded the stock to Sell and has a price target of $0.10.

Twitter is down -9.35% in midday trading to $31.66. Shares opened today at $34.92. The company has a 52-week low of $14.12 and a 52-week high of $36.80. On the Street’s front, the average 12-month analyst price target for the stock is $28.64, marking a -17.98% potential downside from current levels. In a report issued on February 15, Morgan Stanley analyst Brian Nowak maintained a Sell rating on TWTR, with a price target of $28, which implies a downside of 20% from current levels. Separately, on February 12, BMO’s Daniel Salmon maintained a Hold rating on the stock and has a price target of $28. In the last 30 days, insiders have sold $12.18K worth

Read More Here...